News
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
24mon MSNOpinion
The signers acknowledged that leaders of their professions had previously condemned a street protest against lockdown ...
China has barred European medical device companies from selling to its government in response to EU trade restrictions ...
A "Made in China" label doesn't necessarily mean that every component came from that country. Here's how authorities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results